Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2002
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002EP1247523A1 Essential fatty acids in the prevention of cardiovascular events
10/09/2002EP1246919A1 Progenitor cell preservation factors and related methods and products
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246829A1 Novel heterocycles
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246792A1 Compounds and compositions for delivering active agents
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246627A2 Polyanhydrides with biologically active degradation products
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002EP1246538A1 Thickened oil compositions of edible oil
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002EP0991416B1 A universally applicable blood plasma
10/09/2002EP0964856B1 Bicyclic amino acids
10/09/2002EP0772590B1 Thrombin inhibitors
10/09/2002CN1373766A Phosphonic acid derivs, having carboxypeptidase B inhibitory activity
10/09/2002CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1372963A Medicine for refreshing brain and nourishing blood
10/09/2002CN1092055C Chinese medicine preparation
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6461647 Method of preparing red ginseng extract
10/08/2002CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/08/2002CA2126680C Novel megakaryocyte potentiator
10/08/2002CA2084489C Crystalline fumaric acid salts of 9,9-alkylene-3, 7-diazabicyclononane compounds and pharmaceutical compositions containing them
10/03/2002WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002WO2002077218A1 Coagulation factor vii derivatives
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077031A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same,
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076983A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076921A1 Gallic acid derivatives and use for exploring endogenetic coagulation
10/03/2002WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002WO2002076501A2 Blood cell production via activation of the hemoglobin scavenger receptor
10/03/2002WO2002076475A2 Glycosaminoglycan anticoagulants derived from fish
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002WO2002029073A3 Gene delivery vectors for stem cells
10/03/2002WO2002026731A3 Quaternary amidino based inhibitors of factor xa
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2002002751A3 Alteration of cell membrane
10/03/2002WO2001098515A3 Gene-regulating conjugates
10/03/2002WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001017508A9 Cationic liposome delivery of taxanes to angiogenic blood vessels
10/03/2002WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020142995 To enhance the ability of mammalian red blood cells to deliver oxygen, by delivering ligand for the allosteric site of hemoglobin to the cytoplasm of the red blood cells
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002US20020142373 Tissue factor protein variants
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002US20020142029 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments
10/03/2002US20020141992 Deactivation of collagen receptors
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141970 Stabilized with chelate compound; storage stability
10/03/2002US20020139378 Method for creating a separation of posterior cortical vitreous from the retina of the eye
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2442080A1 A preparation for restenosis prevention
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441580A1 Coagulation factor vii derivatives
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441201A1 Thrombin and anhydrothrombin with modified carboxyl groups
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2407779A1 Gallic acid derivatives and use for exploring endogenetic coagulation
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 671